Unknown

Dataset Information

0

Optimizing engineered TCR T cell therapy for synovial sarcoma

ABSTRACT:

SUBMITTER: D'Angelo S 

PROVIDER: S-EPMC4645508 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Current status of engineered T-cell therapy for synovial sarcoma.
| S-EPMC5618931 | biostudies-literature
Unknown Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma.
| S-EPMC9458750 | biostudies-literature
Unknown Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors.
| S-EPMC7761868 | biostudies-literature
Unknown TCR-engineered T cell therapy in solid tumors: State of the art and perspectives.
| S-EPMC9931212 | biostudies-literature
Unknown Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.
| S-EPMC5959255 | biostudies-literature
Unknown Targeting Glutamine Transporters as a Novel Drug Therapy for Synovial Sarcoma.
| S-EPMC12784809 | biostudies-literature
Unknown Primary pulmonary synovial sarcoma.
| S-EPMC9390693 | biostudies-literature
Unknown Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
| S-EPMC4320664 | biostudies-literature
Unknown Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy
| S-EPMC10950868 | biostudies-literature
Unknown BUB1 an Overexpressed Kinase in Sarcoma: Finding New Target Therapy for Osteosarcoma, Liposarcoma, Synovial Sarcoma, and Leiomyosarcoma.
| S-EPMC12293735 | biostudies-literature